CS

Chandra Sekhara Rao Gudipati

Active Director Director DIN 10879582
DIN 10879582 First appointment Dec 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandra Sekhara Rao Gudipati

Data last updated:

Chandra Sekhara Rao Gudipati is a Director at Maxgene Pharma Care Private Limited (since 2024).

DIN 10879582
Primary Designation Director
First Appointment 20 Dec 2024
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maxgene Pharma Care Private Limited U46497MH2024PTC436798
Director20 Dec 20242024Active

Board colleagues of Chandra Sekhara Rao Gudipati

NameDINCompanyDesignation
Vinay Guptha Gudipati10879583Maxgene Pharma Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Maxgene Pharma Care Private Limited
Premium access

Shareholding and investment profile for Chandra Sekhara Rao Gudipati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Sekhara Rao Gudipati

Chandra Sekhara Rao Gudipati currently holds 1 directorship: Maxgene Pharma Care Private Limited (Director, since 20 Dec 2024).

Chandra Sekhara Rao Gudipati was first appointed on 20 Dec 2024 as Director at Maxgene Pharma Care Private Limited.

The current boards of Chandra Sekhara Rao Gudipati's companies include Vinay Guptha Gudipati (Maxgene Pharma Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available